Article · 20 Jun 2025
Research articlePublished 2020
Potent and Broad Spectrum Natural Products Against all Genotypes of Hepatitis C Virus (HCV)
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Infection by hepatitis C virus (HCV) and its subsequent complications are a major cause of mortality worldwide1. In the present study, we performed a phytochemical investigation of the water extract of the leaves of the wild Egyptian artichoke (WEA) (Cynara cardunculus L. var. sylvestris) and subsequently we evaluated its inhibition capacity in vitro using cell-culture derived HCV. The chemical investigation of the WEA extract resulted in the identification of six compounds: a new sesquiterpene lactone (1), in addition to the known compounds (2-6). The structural elucidation of compounds (1-6) was done by extensive spectroscopic tools such as NMR and HR-MS spectroscopy. The absolute configuration was determined by TDDFT ECD calculations and comparison with the experimental CD spectra. The quantitative determination was determined through UPLC-MS quantitation. Importantly, all compounds inhibited HCV infection; compounds 1 and 2 were the most potent among the six. The EC50 were estimated at 1.03 μM, 1.27 μM and 299 μM for compounds 1, 2 and WEA extract, respectively, by using a luciferase-carrying reporter virus2. Time-of-addition experiments revealed that compounds 1 and 2 inhibit HCV virus at a time-point during entry. Furthermore, compounds 1 and 2, apart from cell-free infection inhibited HCV cell-cell transmission, too. Finally, we showed that compounds 1 and 2 inhibited HCV particles from genotypes 1a, 1b, 2b, 3a, 4a, 5a, 6a and 7a indicating that these compounds inhibit HCV cell entry independently of viral genotype or subtype. Thus, these compounds are promising candidates for the development of new pangenotypic entry inhibitors for the HCV infection.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in American Journal of Drug Delivery and Therapeutics.
Article · 1 Apr 2025
Unveiling Pharmacokinetics: The Dynamic Journey of Drugs in the Body
Article · 1 Apr 2025
Innovations in Drug Delivery Systems: Paving the Way for Precision Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAmerican Journal of Drug Delivery and Therapeutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mahmoud F. Elsebai”